Pfizer Stock News

Watch Video A new study determined Pfizer''s vaccine for children doesn''t provide significant protection. SEE MORE: New York To Lift Statewide School Mask Mandate According to the New York State Department of Health, the effectiveness plunged from 68% to 12% in kids ages 5-11 during the Omicron surge. Public health officials believe it may be because of the lower dosage that age group was given. New York city is set to end its mask mandate March 7.

''These results highlight the continued importance of layered protections, including mask wearing''

Scientists at New York’s health department found that the efficacy of Pfizer''s Covid-19 vaccine dropped dramatically in young children, and say that masking remains important.

Pfizer Vaccine Far Less Effective In 5-11 Year-Olds, Latest Data Show As it turns out, the Pfizer vaccine is almost entirely ineffective in children ages 5-11, according to the latest batch of trial data released by the vaccine giant. Here''s more from the NYT: The coronavirus vaccine made by Pfizer-BioNTech is much less effective in preventing infection in children ages 5 to 11 years than in older adolescents or adults, according to a large new set of data collected by health officials in New York State — a finding that has deep ramifications for these children and their parents. The Pfizer vaccine is the only Covid shot authorized for that age group in the United States. It still prevents severe illness in the children, but offers virtually no protection against infection, even within a month after full immunization, the data, which were collected during the Omicron surge, suggest. The scientists who led the study noted that the jab was far less effective and that the data weaken the argument for mandating the jabs in children. "It certainly weakens the argument for mandating that people get that lower dose," said Dr.

Two doses of the Pfizer Inc and BioNTech COVID-19 vaccine was protective against severe disease in children aged 5 to 11 during the recent omicron variant surge, but quickly lost… Read more » The post Study: Pfizer/BioNTech COVID Vaccine Less Effective in Ages 5-11 appeared first on Hamodia .

The Pfizer-BioNtech COVID-19 vaccine that was supposed to protect kids ages 5 to 11 from catching the virus with a 68% efficacy rate has now been outed as nearly ineffective. Its efficacy rate it actually only, get this, 12%. Another day, another one bites the dust. The running theme here …

With the signing of the new Electoral Act 2022 by President Muhammadu Buhari last week Friday, the coast is clear now for political activities to gather more momentum. The 2023 election is very important to Nigeria in more ways than one. It is going to be a fresh start after a two-term of eight years by Buhari. It is also an election that will test the political might of the parties, particularly, the two major ones- the All Progressives Congress (APC) and the People’s Democratic Party (PDP). Will the APC retain the seat or otherwise? Moreover, it is going to test the extent to which the provisions in the Amended Electoral Act that has been signed into law would be implemented and adhered to. BusinessDay Politics and Data Analytics desks have been mandated to provide unbiased analysis and support to the electioneering processes through the provision of timely information on the aspirants, their profiles, achievements, programmes, manifestoes, and interviews blended with superior analysis of economic and election data.

Pfizer (PFE) is trading lower in the pre-market Tuesday after the company announced that its pivotal Phase 3 study for Clostridioides difficile vaccine candidate (PF-06425090) did not…

Pfizer Inc said on Tuesday its vaccine to prevent infections from the clostridioides difficile bacteria failed to meet the main goal of a late-stage study.

Researchers from the New York State Department of Health and the University at Albany School of Public Health, US, estimated the effectiveness of Pfizer vaccine against COVID cases and hospitalisations. They used data from 852,384 fully-vaccinated children of 12-17 years of age and 365,502 children aged 5-11 years during December, 2021 and January, 2022.

The COVID-19 vaccine developed by Pfizer and German partner BioNTech SE is much less effective in preventing infection in children aged 5 to 11 than in older people, according to a new dataset from health officials in New York state, the New York Times reported. For now, the Pfizer/BioNTech shot is the only one authorized for use in that age group. And while it still protects against severe disease, it offers hardly any protection against infection, even within a month after full immunization, according to the data, which were collected during the recent surge caused by the highly infectious omicron variant. The vaccine''s poorer performance may stem from the fact that children are given one-third the dose offered to older children and adults, officials and researchers said, [l: according to the Times. The vaccine has also performed weakly in children aged 2 to 4 years old, who were given an even smaller dose. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.

The study examined Pfizer vaccine effectiveness from December 13, 2021 to January 30, 2022, among 852,384 fully-vaccinated children 12-17 years and 365,502 children 5-11 years

New York, March 1 (IANS) Pfizer’s Covid vaccine for children aged 5 to 11 has proved to be significantly less effective than in older adolescents or adults against the infectious virus, according to a study. The yet to be peer-reviewed study, led by The New York State Department of Health, found that during the Omicron […] The post Pfizer Covid vaccine less effective in kids 5 to 11: Study appeared first on Buziness Bytes .

The decision was reflected in the amended approval for emergency use of the Comirnaty shots originally signed in June last year.

Nora Gossett, 7, reacts as she receives the Pfizer-BioNTech COVID-19 vaccine from Sophia Jan, MD, while her father Jeff Gossett, MD, holds her hand at Cohen Children’s Medical Center as vaccines were approved for children aged 5-11, amid the coronavirus disease pandemic, in New Hyde Park, New York, November 4, 2021. Andrew Kelly | Reuters […] The post Pfizer vaccine was just 12% effective for kids in omicron surge: study appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .